Estimating Long-term Heterogeneous Dose-response Curve: Generalization Bound Leveraging Optimal Transport Weights
Yang, Zeqin, Chen, Weilin, Cai, Ruichu, Yan, Yuguang, Hao, Zhifeng, Yu, Zhipeng, Zou, Zhichao, Xu, Jixing, Peng, Zhen, Guo, Jiecheng
–arXiv.org Artificial Intelligence
Long-term treatment effect estimation is a significant but challenging problem in many applications. Existing methods rely on ideal assumptions, such as no unobserved confounders or binary treatment, to estimate long-term average treatment effects. However, in numerous real-world applications, these assumptions could be violated, and average treatment effects are insufficient for personalized decision-making. In this paper, we address a more general problem of estimating long-term Heterogeneous Dose-Response Curve (HDRC) while accounting for unobserved confounders and continuous treatment. Specifically, to remove the unobserved confounders in the long-term observational data, we introduce an optimal transport weighting framework to align the long-term observational data to an auxiliary short-term experimental data. Furthermore, to accurately predict the heterogeneous effects of continuous treatment, we establish a generalization bound on counterfactual prediction error by leveraging the reweighted distribution induced by optimal transport. Finally, we develop a long-term HDRC estimator building upon the above theoretical foundations. Extensive experiments on synthetic and semi-synthetic datasets demonstrate the effectiveness of our approach.
arXiv.org Artificial Intelligence
Oct-23-2025
- Country:
- Asia > China
- Guangdong Province > Shantou (0.04)
- North America > United States (0.04)
- Asia > China
- Genre:
- Research Report > Experimental Study (1.00)
- Industry:
- Health & Medicine > Therapeutic Area > Oncology (0.67)
- Technology: